ATLANTA, GA -- (MARKET WIRE) -- February 16, 2007 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it will release its fourth quarter and full-year 2006 financial results on Thursday, February 22, 2007, before the U.S. financial markets open.
